Press release
Kidney Transplant Rejection Market Overview: Major Segments, Strategic Developments, and Leading Companies
Kidney Transplant Rejection Market
Projected Market Growth of the Kidney Transplant Rejection Industry
The kidney transplant rejection market is poised for significant expansion, reaching an estimated value of $5.01 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 7.4%. Factors propelling this increase include heightened demand for tailored immunosuppression protocols, wider adoption of molecular diagnostic tools, and the growing influence of precision medicine in transplant care. Additionally, investments in transplant monitoring technologies and a stronger focus on ensuring long-term graft survival are expected to boost market momentum. Key trends driving this market forward encompass the rising use of biomarker-based monitoring for rejection, the integration of genomics in diagnostics, refinement of immunosuppressive therapies, expansion of non-invasive surveillance methods, and greater emphasis on early detection of chronic rejection.
Download a free sample of the kidney transplant rejection market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33190&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Feb_PR
Leading Companies Shaping the Kidney Transplant Rejection Market
Several prominent companies hold significant positions within the kidney transplant rejection market. These include F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Asahi Kasei Corporation, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., ChugAI Pharmaceutical Co. Ltd., Eurofins Scientific SE, Illumina Inc., Natera Inc., CareDx Inc., Azurity Pharmaceuticals Inc., Insight Molecular Diagnostics, and RenalytixAI plc.
In a notable move in July 2024, US-based Biogen Inc. acquired Human Immunology Biosciences, a clinical-stage biotechnology firm specializing in kidney transplant rejection solutions. This acquisition is aimed at enhancing Biogen's immunology and rare diseases portfolio by bringing in advanced therapeutic assets and expertise in immune-mediated conditions.
View the full kidney transplant rejection market report:
https://www.thebusinessresearchcompany.com/report/kidney-transplant-rejection-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Feb_PR
Emerging Trends Transforming Kidney Transplant Rejection Diagnosis
Innovative diagnostic approaches are becoming central to the kidney transplant rejection field, particularly methods that are noninvasive and rapid. Noninvasive urinary biomarker testing is gaining traction as it offers a safer, more convenient way to detect signs of transplant rejection by analyzing urine samples for molecular indicators of inflammation. This method reduces reliance on invasive biopsy procedures, leading to quicker and less burdensome patient assessments.
An example of this innovation is the CXCL10 testing service launched in May 2024 by Thermo Fisher Scientific Inc., a US biotechnology leader. The CXCL10 assay identifies the chemokine CXCL10 in urine, a marker linked to early transplant rejection and inflammation. Results are delivered within 24 hours, facilitating prompt clinical decisions and minimizing unnecessary biopsies. Developed by Thermo Fisher's One Lambda Laboratories, this highly sensitive and specific test is designed for ease of use in clinical settings, supporting improved care and outcomes for kidney transplant recipients.
Comprehensive Segmentation of the Kidney Transplant Rejection Market
This market is segmented into several categories to provide a detailed understanding of its scope:
1) By Rejection Type:
- Chronic Rejection
- Acute Rejection
2) By Treatment:
- Immunosuppressive Drugs
- Antibody-Mediated Rejection Therapies
3) By Diagnostic Approach:
- Biomarker-Based Diagnostics
- Genomics-Based Diagnostics
4) By Therapeutics:
- Small Molecule Inhibitors
- Biologic Therapies
5) By End-Users:
- Transplant Centers or Hospitals
- Diagnostic Laboratories
- Pharmacies
Further subcategories refine these segments:
- Chronic Rejection includes antibody mediated chronic rejection, chronic allograft nephropathy, interstitial fibrosis and tubular atrophy, vascular chronic rejection, and mixed chronic rejection.
- Acute Rejection covers cellular acute rejection, antibody mediated acute rejection, hyperacute rejection, mixed acute rejection, and vascular acute rejection.
This detailed segmentation highlights the diverse range of treatment and diagnostic options as well as the end-user settings that define the kidney transplant rejection market's landscape moving forward.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Transplant Rejection Market Overview: Major Segments, Strategic Developments, and Leading Companies here
News-ID: 4402280 • Views: …
More Releases from The Business Research Company
Leading Companies Enhancing Their Roles in the AI Infrastructure Security Market
The AI infrastructure security sector is rapidly gaining importance as organizations increasingly rely on artificial intelligence systems. Ensuring these systems remain protected from evolving cyber threats is becoming a priority, driving investment and innovation in this specialized market. Let's explore the current market size, leading players, key trends, and market segmentation to understand where this industry is headed.
AI Infrastructure Security Market Size and Growth Projections
The AI infrastructure security…
Market Driver Insights: The Impact of Recent Advancements on the Artificial Inte …
The artificial intelligence large language models market is set to undergo rapid expansion in the coming years, driven by technological advancements and growing enterprise adoption. As organizations increasingly incorporate AI into their operations, the demand for sophisticated language models is rising sharply. Let's delve into the market's current size, key players, emerging trends, and the segmentation that defines this fast-moving industry.
Projected Growth and Market Size of Artificial Intelligence Large Language…
Future Perspectives: Key Trends Shaping the Abdominal Surgical Robot Market Unti …
The abdominal surgical robot market is on the brink of significant expansion as advancements in medical robotics continue to revolutionize surgical procedures. With increasing adoption of technology-driven solutions and rising demand for precision in surgeries, this sector is poised for impressive growth through the coming decade. Here is an overview of the market's future projections, key players, emerging trends, and segmentation.
Abdominal Surgical Robot Market Size and Growth Projections Through 2030…
Artificial Intelligence (AI) Center of Excellence Toolkit Market Overview, Key T …
The artificial intelligence (AI) center of excellence toolkit market is set for remarkable expansion over the coming years. With advances in technology and the growing integration of AI across industries, this sector is poised to deliver substantial value by 2030. Let's explore the market's size, key drivers, major players, trends, and the segmentation that shape its promising future.
Projected Market Value and Growth Prospects for the AI Center of Excellence Toolkit…
More Releases for Rejection
Rejection after rejection: Why individual AVGS job coaching increases your chanc …
Berlin, 17.12.2025 - Despite the shortage of skilled workers, many jobseekers experience a frustrating reality: they write numerous applications, but receive hardly any invitations to interviews or only rejections. In particular, people who are receiving "B?rgergeld" or have been unemployed for a long time are increasingly losing their connection to the labor market.
Labor market experts see a key reason for this development in outdated application strategies and a lack of…
Antibody-mediated Rejection Market Dynamics, Innovations and Growth
Organ transplantation has been one of the most remarkable achievements of modern medicine, offering patients with end-stage organ failure a renewed chance at life. However, antibody-mediated rejection (AMR) remains a major complication following kidney, heart, lung, and liver transplants, significantly affecting long-term graft survival. AMR occurs when donor-specific antibodies (DSAs) attack the transplanted organ, leading to immune injury and often graft loss.
Download Full PDF Sample Copy of Market Report @…
Global Nitrogen Rejection Units Market Analysis (2024-2029)
LPI (LP Information)' newest research report, the "Nitrogen Rejection Units Industry Forecast" looks at past sales and reviews total world Nitrogen Rejection Units sales in 2024, providing a comprehensive analysis by region and market sector of projected Nitrogen Rejection Units sales for 2024 through 2029. With Nitrogen Rejection Units sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world…
Transplant Rejection Treatment Market-Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Transplant Rejection Treatment Market is projected to grow from USD 5.6 billion in 2021 to USD 6.9 billion by 2026 at a CAGR value of 4.2% from 2021 to 2026.
Increasing number of research and developmental activities related to transplant rejection procedure, increasing demand for transplant surgeries, rising chronic disease prevalence and high disposable income are…
Jobbatical brings candidate rejection messaging to Jobbatical.com
Tallinn, Estonia – June 8, 2017 – Jobbatical product innovation continues with the ability to send rejection messaging to candidates directly from our platform.
Jobbatical continues to make it easier for hiring managers to source and evaluate applicants on our platform. Now we’ve implemented an easy to use rejection function with the option to use a template letter or personalized response to reject the candidate. As a hiring manager, it’s…
Liver Transplant Rejection - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Liver Transplant Rejection - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Transplant Rejection - Pipeline Review, H1 2017, provides an overview of the Liver Transplant Rejection (Immunology) pipeline landscape.
Liver transplantation is the conventional therapy used in various liver diseases. Liver has the unique ability…
